[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fVGUFjygk8rHUj3nKjzlmM4e2NnRt5vlKYRgMw8rYrl4":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":53,"rows":60},"Centre Hospitalier Departemental Vendee",[4],82,false,16,7,30606,4,66,[14,16,19,21,23,25,28,30],{"name":15,"count":11},"Cardiac Arrest",{"name":17,"count":18},"Pregnancy",3,{"name":20,"count":18},"Acute Respiratory Failure",{"name":22,"count":18},"Shock",{"name":24,"count":18},"Ventilator-associated Pneumonia",{"name":26,"count":27},"Breast Cancer",2,{"name":29,"count":27},"Delivery",{"name":31,"count":27},"Hypothermia",[33,38,43,48],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT05288985","Impact of Loco-regional Analgesia Following Placement of Erector Spinae Plane Catheter in Addition to Systemic Analgesia in Patients With Thoracic Trauma","2026-01-14","Systemic Analgesia Only Group",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT05045157","Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders","2026-05-31","Corticosteroid",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT06376981","Hyaluronic Acid in Shoulder Tendinopathy","2026-12-19","Hyaluronic acid",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT03323476","Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease","2028-03","Maintenance (or initiation) of immunosuppressive treatment: Imurel®, Mabthera®,Cellcept®, Cortancyl®",[54,55,56,57,58,59],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[61,95,118,136,157,185,203,229,254,272,298,324,350,368,393,411,459,482],{"intervention":42,"totalTrials":27,"cells":62},{"EARLY_PHASE1":63,"PHASE1":66,"PHASE2":68,"PHASE3":70,"PHASE4":82,"NA":84},{"trials":64,"activeCount":65},[],0,{"trials":67,"activeCount":65},[],{"trials":69,"activeCount":65},[],{"trials":71,"activeCount":81,"soonestReadout":46},[72],{"nctId":44,"briefTitle":45,"status":73,"phases":74,"primaryCompletion":46,"completion":75,"start":76,"enrollment":77,"conditions":78,"interventions":80},"RECRUITING",[57],"2027-03-19","2024-09-19",132,[79],"Shoulder Tendinitis",[47,42],1,{"trials":83,"activeCount":65},[],{"trials":85,"activeCount":81,"soonestReadout":41},[86],{"nctId":39,"briefTitle":40,"status":87,"phases":88,"primaryCompletion":41,"completion":89,"start":90,"enrollment":91,"conditions":92,"interventions":94},"ACTIVE_NOT_RECRUITING",[59],"2027-05-31","2022-05-31",50,[93],"Trigger Finger",[42],{"intervention":52,"totalTrials":81,"cells":96},{"EARLY_PHASE1":97,"PHASE1":99,"PHASE2":101,"PHASE3":103,"PHASE4":114,"NA":116},{"trials":98,"activeCount":65},[],{"trials":100,"activeCount":65},[],{"trials":102,"activeCount":65},[],{"trials":104,"activeCount":81,"soonestReadout":51},[105],{"nctId":49,"briefTitle":50,"status":87,"phases":106,"primaryCompletion":51,"completion":107,"start":108,"enrollment":109,"conditions":110,"interventions":113},[57],"2031-03","2018-02-02",136,[111,112],"Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis","End Stage Renal Disease",[52],{"trials":115,"activeCount":65},[],{"trials":117,"activeCount":65},[],{"intervention":47,"totalTrials":81,"cells":119},{"EARLY_PHASE1":120,"PHASE1":122,"PHASE2":124,"PHASE3":126,"PHASE4":132,"NA":134},{"trials":121,"activeCount":65},[],{"trials":123,"activeCount":65},[],{"trials":125,"activeCount":65},[],{"trials":127,"activeCount":81,"soonestReadout":46},[128],{"nctId":44,"briefTitle":45,"status":73,"phases":129,"primaryCompletion":46,"completion":75,"start":76,"enrollment":77,"conditions":130,"interventions":131},[57],[79],[47,42],{"trials":133,"activeCount":65},[],{"trials":135,"activeCount":65},[],{"intervention":37,"totalTrials":81,"cells":137},{"EARLY_PHASE1":138,"PHASE1":140,"PHASE2":142,"PHASE3":144,"PHASE4":146,"NA":148},{"trials":139,"activeCount":65},[],{"trials":141,"activeCount":65},[],{"trials":143,"activeCount":65},[],{"trials":145,"activeCount":65},[],{"trials":147,"activeCount":65},[],{"trials":149,"activeCount":81,"soonestReadout":36},[150],{"nctId":34,"briefTitle":35,"status":87,"phases":151,"primaryCompletion":36,"completion":36,"start":152,"enrollment":153,"conditions":154,"interventions":156},[59],"2022-07-29",40,[155],"Trauma Abdomen",[37],{"intervention":158,"totalTrials":81,"cells":159},"infiltration of corticosteroids",{"EARLY_PHASE1":160,"PHASE1":162,"PHASE2":164,"PHASE3":166,"PHASE4":168,"NA":183},{"trials":161,"activeCount":65},[],{"trials":163,"activeCount":65},[],{"trials":165,"activeCount":65},[],{"trials":167,"activeCount":65},[],{"trials":169,"activeCount":65},[170],{"nctId":171,"briefTitle":172,"status":173,"phases":174,"primaryCompletion":175,"completion":176,"start":177,"enrollment":178,"conditions":179,"interventions":181},"NCT03431584","Effects on the Pain of an Infiltration by Acid Hyaluronic Association and Corticoids Versus Only Corticoids in the Rhizarthrosis.","COMPLETED",[58],"2021-05-28","2021-12-16","2018-05-11",150,[180],"Rhizarthrosis",[158,182],"infiltration of corticosteroids and hyaluronic acid",{"trials":184,"activeCount":65},[],{"intervention":182,"totalTrials":81,"cells":186},{"EARLY_PHASE1":187,"PHASE1":189,"PHASE2":191,"PHASE3":193,"PHASE4":195,"NA":201},{"trials":188,"activeCount":65},[],{"trials":190,"activeCount":65},[],{"trials":192,"activeCount":65},[],{"trials":194,"activeCount":65},[],{"trials":196,"activeCount":65},[197],{"nctId":171,"briefTitle":172,"status":173,"phases":198,"primaryCompletion":175,"completion":176,"start":177,"enrollment":178,"conditions":199,"interventions":200},[58],[180],[158,182],{"trials":202,"activeCount":65},[],{"intervention":204,"totalTrials":81,"cells":205},"Tacrolimus",{"EARLY_PHASE1":206,"PHASE1":208,"PHASE2":210,"PHASE3":212,"PHASE4":214,"NA":227},{"trials":207,"activeCount":65},[],{"trials":209,"activeCount":65},[],{"trials":211,"activeCount":65},[],{"trials":213,"activeCount":65},[],{"trials":215,"activeCount":65},[216],{"nctId":217,"briefTitle":218,"status":219,"phases":220,"primaryCompletion":221,"completion":221,"start":222,"enrollment":223,"conditions":224,"interventions":226},"NCT03640026","Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients","TERMINATED",[58],"2025-11-10","2019-03-08",61,[225],"Kidney Failure, Chronic",[204],{"trials":228,"activeCount":65},[],{"intervention":230,"totalTrials":81,"cells":231},"Inflammatory biomarkers dosage \"Hypothermia Arm\"",{"EARLY_PHASE1":232,"PHASE1":234,"PHASE2":236,"PHASE3":238,"PHASE4":250,"NA":252},{"trials":233,"activeCount":65},[],{"trials":235,"activeCount":65},[],{"trials":237,"activeCount":65},[],{"trials":239,"activeCount":65},[240],{"nctId":241,"briefTitle":242,"status":173,"phases":243,"primaryCompletion":244,"completion":244,"start":245,"enrollment":246,"conditions":247,"interventions":248},"NCT02711098","IL Ancillary Study of the Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.",[57],"2018-01-14","2016-03",116,[15],[230,249],"Inflammatory biomarkers dosage \"Normothermia Arm\"",{"trials":251,"activeCount":65},[],{"trials":253,"activeCount":65},[],{"intervention":249,"totalTrials":81,"cells":255},{"EARLY_PHASE1":256,"PHASE1":258,"PHASE2":260,"PHASE3":262,"PHASE4":268,"NA":270},{"trials":257,"activeCount":65},[],{"trials":259,"activeCount":65},[],{"trials":261,"activeCount":65},[],{"trials":263,"activeCount":65},[264],{"nctId":241,"briefTitle":242,"status":173,"phases":265,"primaryCompletion":244,"completion":244,"start":245,"enrollment":246,"conditions":266,"interventions":267},[57],[15],[230,249],{"trials":269,"activeCount":65},[],{"trials":271,"activeCount":65},[],{"intervention":273,"totalTrials":81,"cells":274},"neostigmine",{"EARLY_PHASE1":275,"PHASE1":277,"PHASE2":279,"PHASE3":281,"PHASE4":294,"NA":296},{"trials":276,"activeCount":65},[],{"trials":278,"activeCount":65},[],{"trials":280,"activeCount":65},[],{"trials":282,"activeCount":65},[283],{"nctId":284,"briefTitle":285,"status":173,"phases":286,"primaryCompletion":287,"completion":288,"start":289,"enrollment":290,"conditions":291,"interventions":293},"NCT00847938","Comparision of Different Dose of Neostigmine at Advanced Decurarization",[57],"2009-10","2009-11","2009-03",62,[292],"Anesthesia",[273,273,273],{"trials":295,"activeCount":65},[],{"trials":297,"activeCount":65},[],{"intervention":299,"totalTrials":81,"cells":300},"Silodosin",{"EARLY_PHASE1":301,"PHASE1":303,"PHASE2":305,"PHASE3":307,"PHASE4":320,"NA":322},{"trials":302,"activeCount":65},[],{"trials":304,"activeCount":65},[],{"trials":306,"activeCount":65},[],{"trials":308,"activeCount":65},[309],{"nctId":310,"briefTitle":311,"status":219,"phases":312,"primaryCompletion":313,"completion":313,"start":314,"enrollment":315,"conditions":316,"interventions":319},"NCT02090439","Effectiveness of Silodosin in Medical Expulsive Therapy for Ureteral Pelvic Stone From 4 to 10 mm.",[57],"2015-12","2014-07",8,[317,318],"Kidney Stone","Expulsive Medical Therapy",[299],{"trials":321,"activeCount":65},[],{"trials":323,"activeCount":65},[],{"intervention":325,"totalTrials":81,"cells":326},"Administration of Ropivacaïne",{"EARLY_PHASE1":327,"PHASE1":329,"PHASE2":331,"PHASE3":333,"PHASE4":346,"NA":348},{"trials":328,"activeCount":65},[],{"trials":330,"activeCount":65},[],{"trials":332,"activeCount":65},[],{"trials":334,"activeCount":65},[335],{"nctId":336,"briefTitle":337,"status":173,"phases":338,"primaryCompletion":339,"completion":339,"start":340,"enrollment":341,"conditions":342,"interventions":344},"NCT03084549","Study of the Analgesic Effect of the Perineal Infiltration of Ropivacaine 0.75% Versus Placebo in Post-episiotomy Perineal Pain",[57],"2020-11-04","2017-10-24",272,[343],"Episiotomy",[325,345],"Administration of placebo",{"trials":347,"activeCount":65},[],{"trials":349,"activeCount":65},[],{"intervention":345,"totalTrials":81,"cells":351},{"EARLY_PHASE1":352,"PHASE1":354,"PHASE2":356,"PHASE3":358,"PHASE4":364,"NA":366},{"trials":353,"activeCount":65},[],{"trials":355,"activeCount":65},[],{"trials":357,"activeCount":65},[],{"trials":359,"activeCount":65},[360],{"nctId":336,"briefTitle":337,"status":173,"phases":361,"primaryCompletion":339,"completion":339,"start":340,"enrollment":341,"conditions":362,"interventions":363},[57],[343],[325,345],{"trials":365,"activeCount":65},[],{"trials":367,"activeCount":65},[],{"intervention":369,"totalTrials":81,"cells":370},"NSE dosage \"hypothermia arm\"",{"EARLY_PHASE1":371,"PHASE1":373,"PHASE2":375,"PHASE3":377,"PHASE4":389,"NA":391},{"trials":372,"activeCount":65},[],{"trials":374,"activeCount":65},[],{"trials":376,"activeCount":65},[],{"trials":378,"activeCount":65},[379],{"nctId":380,"briefTitle":381,"status":173,"phases":382,"primaryCompletion":244,"completion":383,"start":245,"enrollment":384,"conditions":385,"interventions":387},"NCT02722473","NSE Ancillary Study of The Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.",[57],"2018-08-09",106,[15,31,386],"Critical Care",[369,388],"NSE dosage \"normothermia arm\"",{"trials":390,"activeCount":65},[],{"trials":392,"activeCount":65},[],{"intervention":388,"totalTrials":81,"cells":394},{"EARLY_PHASE1":395,"PHASE1":397,"PHASE2":399,"PHASE3":401,"PHASE4":407,"NA":409},{"trials":396,"activeCount":65},[],{"trials":398,"activeCount":65},[],{"trials":400,"activeCount":65},[],{"trials":402,"activeCount":65},[403],{"nctId":380,"briefTitle":381,"status":173,"phases":404,"primaryCompletion":244,"completion":383,"start":245,"enrollment":384,"conditions":405,"interventions":406},[57],[15,31,386],[369,388],{"trials":408,"activeCount":65},[],{"trials":410,"activeCount":65},[],{"intervention":412,"totalTrials":18,"cells":413},"Ropivacaine",{"EARLY_PHASE1":414,"PHASE1":416,"PHASE2":418,"PHASE3":420,"PHASE4":422,"NA":446},{"trials":415,"activeCount":65},[],{"trials":417,"activeCount":65},[],{"trials":419,"activeCount":65},[],{"trials":421,"activeCount":65},[],{"trials":423,"activeCount":65},[424,435],{"nctId":425,"briefTitle":426,"status":173,"phases":427,"primaryCompletion":428,"completion":428,"start":429,"enrollment":430,"conditions":431,"interventions":434},"NCT02085902","Does the Use of Ropivacaine Facilitates Cholecystectomy by Laparoscopy in Ambulatory Surgery?",[58],"2015-05","2014-03",120,[432,433],"Cholecystectomy","Laparoscopy",[412],{"nctId":436,"briefTitle":437,"status":173,"phases":438,"primaryCompletion":439,"completion":440,"start":441,"enrollment":442,"conditions":443,"interventions":445},"NCT05519189","Evaluation of the Value of Perianal Infiltration During Thermodestruction of Haemorrhoidal Disease by Radiofrequency",[58],"2025-12-16","2026-01-15","2023-01-10",134,[444],"Hemorrhoids",[412],{"trials":447,"activeCount":65},[448],{"nctId":449,"briefTitle":450,"status":173,"phases":451,"primaryCompletion":452,"completion":453,"start":454,"enrollment":455,"conditions":456,"interventions":458},"NCT03998813","Chronic Pain and Functional Prognosis After Total Knee Replacement: Continuous Locoregional Analgesia by Catheter to the Femoral Triangle Versus Tissue Infiltration as Part of an Improved Rehabilitation After Surgery Approach",[59],"2023-06-26","2024-04-08","2020-09-02",287,[457],"Knee Pain Chronic",[412,412],{"intervention":460,"totalTrials":81,"cells":461},"Dinoprostone",{"EARLY_PHASE1":462,"PHASE1":464,"PHASE2":466,"PHASE3":468,"PHASE4":470,"NA":472},{"trials":463,"activeCount":65},[],{"trials":465,"activeCount":65},[],{"trials":467,"activeCount":65},[],{"trials":469,"activeCount":65},[],{"trials":471,"activeCount":65},[],{"trials":473,"activeCount":65},[474],{"nctId":475,"briefTitle":476,"status":219,"phases":477,"primaryCompletion":478,"completion":478,"start":479,"enrollment":27,"conditions":480,"interventions":481},"NCT02649920","Comparing the Efficiency of Cervical Ripening BALLoon (Cook) to the DINOprostone (Propess) for the Cervical Maturation in Case of Unfavorable Cervix (Bishop \u003C6) in the Population of Obese Pregnant Women (BMI >= 30 kg\u002Fm²)",[59],"2016-11","2016-06",[29],[460],{"intervention":483,"totalTrials":81,"cells":484},"Corticosteroids infiltration",{"EARLY_PHASE1":485,"PHASE1":487,"PHASE2":489,"PHASE3":491,"PHASE4":493,"NA":495},{"trials":486,"activeCount":65},[],{"trials":488,"activeCount":65},[],{"trials":490,"activeCount":65},[],{"trials":492,"activeCount":65},[],{"trials":494,"activeCount":65},[],{"trials":496,"activeCount":65},[497],{"nctId":498,"briefTitle":499,"status":219,"phases":500,"primaryCompletion":501,"completion":502,"start":503,"enrollment":504,"conditions":505,"interventions":507},"NCT03951480","Care of AcromioClavicular Arthropathy in Manual Medicine Versus Corticosteroid Infiltration (ACAM)",[59],"2024-08-29","2025-06-06","2020-11-24",35,[506],"Acromioclavicular Arthropathy",[483]]